Predicting a local recurrence after breast-conserving therapy by gene expression profiling.
about
Breast cancer in the personal genomics eraThe impact of the myeloid response to radiation therapyGene expression variation to predict 10-year survival in lymph-node-negative breast cancer.Multidisciplinary approach of early breast cancer: the biology applied to radiation oncology.Validation of a web-based predictive nomogram for ipsilateral breast tumor recurrence after breast conserving therapy.Mechanisms of disease: epithelial-mesenchymal transition--does cellular plasticity fuel neoplastic progression?Association between the 21-gene recurrence score assay and risk of locoregional recurrence in node-negative, estrogen receptor-positive breast cancer: results from NSABP B-14 and NSABP B-20Interferon-induced protein with tetratricopeptide repeats 1 (IFIT1) as a prognostic marker for local control in T1-2 N0 breast cancer treated with breast-conserving surgery and radiation therapy (BCS + RT).MicroRNA-9 as potential biomarker for breast cancer local recurrence and tumor estrogen receptor statusCo-overexpression of GEP100 and AMAP1 proteins correlates with rapid local recurrence after breast conservative therapyThe 21-gene recurrence score complements IBTR! Estimates in early-stage, hormone receptor-positive, HER2-normal, lymph node-negative breast cancer.MicroRNA-mediated drug resistance in breast cancer.Expression of endoplasmic reticulum stress proteins is a candidate marker of brain metastasis in both ErbB-2+ and ErbB-2- primary breast tumorsBMP2 response pattern in human lung fibroblasts predicts outcome in lung adenocarcinomasAudit of local recurrence following breast conservation surgery with 5-mm target margin and hypofractionated 40-Gray breast radiotherapy for invasive breast cancer.Gene expression and hypoxia in breast cancer.Telomere length variation in normal epithelial cells adjacent to tumor: potential biomarker for breast cancer local recurrence.Prognostic Impact of Time to Ipsilateral Breast Tumor Recurrence after Breast Conserving Surgery.Tailoring cancer radiotherapy through genotyping, how close are we?Tumor necrosis is an important hallmark of aggressive endometrial cancer and associates with hypoxia, angiogenesis and inflammation responses.Prognostic value of biologic subtype and the 21-gene recurrence score relative to local recurrence after breast conservation treatment with radiation for early stage breast carcinoma: results from the Eastern Cooperative Oncology Group E2197 studyAre ipsilateral breast tumour invasive recurrences in young (< or =40 years) women more aggressive than their primary tumours?Gene expression profiling in primary breast cancer distinguishes patients developing local recurrence after breast-conservation surgery, with or without postoperative radiotherapyTrue Local Recurrences after Breast Conserving Surgery have Poor Prognosis in Patients with Early Breast Cancer.The 21-gene recurrence score and locoregional recurrence in breast cancer patients.Systems biology and cancer stem cells.How much can improved molecular and pathologic discriminants change local therapy?Local control by radiotherapy: is that all there is?Combining biological gene expression signatures in predicting outcome in breast cancer: An alternative to supervised classificationTumor aromatase expression as a prognostic factor for local control in young breast cancer patients after breast-conserving treatment.Taking advantage of tumor cell adaptations to hypoxia for developing new tumor markers and treatment strategies.Assessment of tumour hypoxia for prediction of response to therapy and cancer prognosis.Genetic variants in the acylphosphatase 2 gene and the risk of breast cancer in a Han Chinese population.Prognostic factors for local recurrence following breast-conserving treatment in young women.Adjuvant therapy in stage I carcinoma of the breast: the influence of multigene analyses and molecular phenotyping.Adjuvant therapy in stage I carcinoma of the breast: the influence of multigene analyses and molecular phenotyping.Tissue banking in a regional hospital: a promising future concept? First report on fresh frozen tissue banking in a hospital without an integrated institute of pathology.Jab1 is a target of EGFR signaling in ERalpha-negative breast cancer.Increased insulin-like growth factor-1 receptor mRNA expression predicts poor survival in immunophenotypes of early breast carcinoma.A taxonomy of organ-specific breast cancer metastases based on a protein-protein interaction network.
P2860
Q24602679-7D72F644-6A03-409F-BD31-F114702DD3DBQ26851643-DB0365DE-2EB3-44FB-9401-2D73E1DA76F4Q33367810-116CF530-D0A2-4C3B-AB4B-7E200269F626Q33657595-079A0FA8-FBF0-46FF-B7F5-EA38743F65F8Q33710551-5EFFD85D-BFD9-4B2B-982A-C6163F064F28Q33755906-9F98EE70-9DF7-4087-9D37-1AF00188B2BDQ33770332-6F60FC6D-C623-4745-B43C-2CE4574E999AQ33924893-F2A95B7F-4094-48E5-A7F0-6FF4FF994312Q34314082-59E36554-32DA-4BF8-A13B-CF7AB8E0926AQ35014893-72EC44F4-D9BB-41CE-A058-37D256FF1F19Q35054821-EA3B243F-D55A-49F3-A131-C859BD991050Q35165126-6B116B1E-ABF9-4718-B56A-40ECFBB25647Q35168104-3063AD37-515C-480A-982E-AEE760402192Q35575590-2F8B539C-2E15-4AEF-9713-6449A23C4F88Q35588667-8D4B0F28-31D6-4598-85A7-E530FF0B7A24Q35614451-FC123ACF-B9FC-444B-9084-4A2151CA5F9BQ35747318-DB0F3BFD-8BCD-4148-950A-CD8BFC9A2B07Q36095773-DCDAF718-5D51-429D-990B-F3915E555793Q36235699-5D998465-B2C3-4867-9566-B379C31E732AQ36545454-A529B8BF-1495-4F9A-8373-2FDECC3F8094Q36554725-C62EE6C5-3655-4D3C-9DB6-C4F0F2B1BF1AQ36611405-4C11C546-6514-44A7-8B0D-1C94767930EBQ36678711-361CDD90-CDEB-419D-BB7A-A192320D34ACQ36839673-46684D16-9817-4DBD-AF38-77F3EB91DE71Q36908670-D912C293-AD0E-405D-8A9A-D2EDB67C5B12Q37010408-506944EB-5DBE-4ADF-B46B-27ED8F719AF1Q37039849-6C63DBF0-BD41-4769-8005-2A75FA7A5BE3Q37131386-E3AEAB52-14F5-43B6-851D-AC55FF3C554EQ37131531-601564E3-F1FA-41D4-8B06-5AECBB6930B6Q37360208-AD7E87A9-BE3D-4BDE-8ABD-48ED54A283BDQ37426436-41E19D9C-DFE7-4F82-9A1D-C5EA28ADB87EQ37617542-90DCECA2-6E2C-4FE4-A5BB-80E3DC46AE88Q37699319-06EC76A7-8D72-4E64-AA03-B312CBA7A7EEQ37782089-112D5156-C321-4C77-BD34-3898A6A6B2D7Q37990824-85B88A98-A3B4-4CC8-8547-E479194B5467Q38023589-097D8E5B-95CC-4649-90F7-1143E818D7DFQ39612569-4D091300-2F15-47CB-BE9D-D9FF9AAA63CAQ39974866-B77DB933-FE38-4469-8B57-3F2482AF64B5Q42479574-B4019589-4651-4112-A876-1C76242D927FQ43551742-279ED194-4AE7-4682-A4FD-3A8DD0B07B50
P2860
Predicting a local recurrence after breast-conserving therapy by gene expression profiling.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Predicting a local recurrence ...... by gene expression profiling.
@ast
Predicting a local recurrence ...... by gene expression profiling.
@en
type
label
Predicting a local recurrence ...... by gene expression profiling.
@ast
Predicting a local recurrence ...... by gene expression profiling.
@en
prefLabel
Predicting a local recurrence ...... by gene expression profiling.
@ast
Predicting a local recurrence ...... by gene expression profiling.
@en
P2093
P2860
P50
P356
P1476
Predicting a local recurrence ...... by gene expression profiling.
@en
P2093
Augustinus A M Hart
Dimitry S A Nuyten
Hans J Peterse
Harry Bartelink
Howard Y Chang
Jen-Tsan Ashley Chi
Julie B Sneddon
Lodewyk F A Wessels
P2860
P2888
P356
10.1186/BCR1614
P577
2006-01-01T00:00:00Z
P5875
P6179
1030320001